Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 31;194(4):E112-E121.
doi: 10.1503/cmaj.211277.

Outcomes in patients with and without disability admitted to hospital with COVID-19: a retrospective cohort study

Affiliations

Outcomes in patients with and without disability admitted to hospital with COVID-19: a retrospective cohort study

Hilary K Brown et al. CMAJ. .

Erratum in

Abstract

Background: Disability-related considerations have largely been absent from the COVID-19 response, despite evidence that people with disabilities are at elevated risk for acquiring COVID-19. We evaluated clinical outcomes in patients who were admitted to hospital with COVID-19 with a disability compared with patients without a disability.

Methods: We conducted a retrospective cohort study that included adults with COVID-19 who were admitted to hospital and discharged between Jan. 1, 2020, and Nov. 30, 2020, at 7 hospitals in Ontario, Canada. We compared in-hospital death, admission to the intensive care unit (ICU), hospital length of stay and unplanned 30-day readmission among patients with and without a physical disability, hearing or vision impairment, traumatic brain injury, or intellectual or developmental disability, overall and stratified by age (≤ 64 and ≥ 65 yr) using multivariable regression, controlling for sex, residence in a long-term care facility and comorbidity.

Results: Among 1279 admissions to hospital for COVID-19, 22.3% had a disability. We found that patients with a disability were more likely to die than those without a disability (28.1% v. 17.6%), had longer hospital stays (median 13.9 v. 7.8 d) and more readmissions (17.6% v. 7.9%), but had lower ICU admission rates (22.5% v. 28.3%). After adjustment, there were no statistically significant differences between those with and without disabilities for in-hospital death or admission to ICU. After adjustment, patients with a disability had longer hospital stays (rate ratio 1.36, 95% confidence interval [CI] 1.19-1.56) and greater risk of readmission (relative risk 1.77, 95% CI 1.14-2.75). In age-stratified analyses, we observed longer hospital stays among patients with a disability than in those without, in both younger and older subgroups; readmission risk was driven by younger patients with a disability.

Interpretation: Patients with a disability who were admitted to hospital with COVID-19 had longer stays and elevated readmission risk than those without disabilities. Disability-related needs should be addressed to support these patients in hospital and after discharge.

PubMed Disclaimer

Conflict of interest statement

Competing interests: Amol Verma has received personal fees from Ontario Health, and personal grant funding from AMS Healthcare (Compassion and AI Fellowship) and St. Michael’s Hospital. Michael Fralick is a consultant for Proof Diagnostics, a company that has created a point-of-care testing device using CRISPR for COVID-19. He has also received grants from the Canadian Institutes of Health Research (CIHR) and support from grants from the Canadian Military for clinical trials to identify treatments for COVID-19. Fahad Razak has received personal fees from Ontario Health and is a member of the Ontario COVID-19 Science Advisory Table. Yona Lunsky has received a grant from CIHR for research on disability and health during COVID-19. She is a member of the Board of Directors for Special Olympics Canada. Margaret Herridge has received grants from CIHR. No other competing interests were declared.

Figures

Figure 1:
Figure 1:
Risk of death among patients with and without a disability who were admitted to hospital with COVID-19. We adjusted all models for hospital site as a fixed effect. Model 1 was further adjusted for age, sex and residence in a long-term care facility. Model 2 was further adjusted for medical comorbidity, dementia and psychiatric disorders. Model 3 was further adjusted for predicted risk of death at presentation to hospital. Model 4 was further adjusted for neighbourhood-level income and proportions of patients who identified as a visible minority. Note: CI = confidence interval, RR = relative risk.
Figure 2:
Figure 2:
Risk of admission to the intensive care unit among patients with and without a disability who were admitted to hospital with COVID-19. We adjusted all models for hospital site as a fixed effect. Model 1 was further adjusted for age, sex and residence in a long-term care facility. Model 2 was further adjusted for medical comorbidity, dementia and psychiatric disorders. Model 3 was further adjusted for predicted risk of death at presentation to hospital. Model 4 was further adjusted for neighbourhood-level income and proportions of patients who identified as a visible minority. Note: CI = confidence interval, RR = relative risk.
Figure 3:
Figure 3:
Length of hospital stay among patients with and without a disability who were admitted to hospital with COVID-19. We adjusted all models for hospital site as a fixed effect. Model 1 was further adjusted for age, sex and residence in a long-term care facility. Model 2 was further adjusted for medical comorbidity, dementia and psychiatric disorders. Model 3 was further adjusted for predicted risk of death at presentation to hospital. Model 4 was further adjusted for neighbourhood-level income and proportions of patients who identified as a visible minority. Note: CI = confidence interval, IQR = interquartile range.
Figure 4:
Figure 4:
Risk of unplanned 30-day readmission to hospital among patients with and without a disability who were admitted to hospital with COVID-19. We adjusted all models for hospital site as a fixed effect. Model 1 was further adjusted for age, sex and residence in a long-term care facility. Model 2 was further adjusted for medical comorbidity, dementia and psychiatric disorders. Model 3 was further adjusted for predicted risk of death at presentation. Model 4 was further adjusted for neighbourhood-level income and proportions of patients who identified as a visible minority. Note: CI = confidence interval, RR = relative risk.

References

    1. Morciano M, Stokes J, Kontopantelis E, et al. . Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study. BMC Med 2021;19:71. - PMC - PubMed
    1. Karmakar M, Lantz PM, Tipirneni R. Association of social and demographic factors with COVID-19 incidence and death rates in the US. JAMA Netw Open 2021;4:e2036462. - PMC - PubMed
    1. Yanez ND, Weiss NS, Romand JA, et al. . COVID-19 mortality risk for older men and women. BMC Public Health 2020;20:1742. - PMC - PubMed
    1. Christensen DM, Strange JE, Gislason G, et al. . Charlson Comorbidity Index score and risk of severe outcome and death in Danish COVID-19 patients. J Gen Intern Med 2020;35:2801–3. - PMC - PubMed
    1. World report on disability. Geneva: World Health Organization; 2011. - PubMed

Publication types

MeSH terms